Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Dose and Timing for PONV
NCT03297021Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Oct 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ondansetron in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Icahn School of Medicine at Mount Sinai. Primary endpoints: Incidence of Post-operative Nausea and Vomiting and Nausea Scale Score. Started Oct 2017; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03297021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03297021.